Abstract
An oral test dose of diazepam was given to 25 anxious neurotics before they received three weeks of treatment with the drug. Blood was taken at 1 h and 2 h after the test dose (and during subsequent treatment) and the plasma levels of diazepam at these times were assayed. Ratings to assess subsequent clinical response were made in the context of a double-blind trial.
The 2 h plasma level correlated positively with the steady-state plasma level of diazepam after one week of treatment.
There was a statistically strong link between a low 2 h plasma diazepam level and improvement after the first week of treatment. This correlation of low pretreatment plasma level with good response suggests either that there may be an avid uptake of diazepam from the blood in those who are going to improve clinically as a result of its administration, or that good responders have a special ability to form active metabolites of diazepam.
A high 2 h plasma level was found in those patients who reported increased tiredness during the three weeks on diazepam.
The 1 h plasma diazepam level, in contradistinction, had but negligible correlations with steady-state levels, with clinical response and with diazepam-induced tiredness.
Similar content being viewed by others
References
Alexanderson, B.: Pharmacokinetics of Nortriptyline in man after single and multiple oral doses: The predictability of the steady-state plasma concentration from single-dose plasma-level data. Europ. J. clin. Pharmacol. 4, 82–91 (1972)
Berlin, A., Siwers, B., Agurell, S., Hort, A., Sjöqvist, F., Ström, S.: Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clin. Pharmacol. Ther. 13, 733–744 (1972)
Bianchi, G. N., Phillips, J.: A comparative trial of doxepin and diazepam in anxiety states. Psychopharmacologia (Berl.) 25, 86–95 (1972)
Boston Drug Surveillance Program: Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. New Engl. J. Med. 288, 277–280 (1973)
Braithwaite, R. A., Goulding, R., Theano, G., Bailey, J., Coppen, A.: Plasma concentration of amitriptyline and clinical response. Lancet 1972 I, 1297–1300
Garattini, S., Marcucci, F., Morselli, P. L., Mussini, E.: The significance of measuring blood levels of benzodiazepines. In: Biological effects of drugs in relation to their plasma concentrations (Eds. D. S. Davies and B. N. C. Prichard). London: Macmillan 1973
Hamilton, M.: Diagnosis and rating of anxiety. In: Studies in anxiety, M. H. Lader, Ed., pp. 76–79. Ashford: R. M. P. A. Invicta Press 1969
IdÄnpÄÄn-HeikkilÄ, J. E., Taska, R. J., Allen, H. A., Schoolar, J. C.: Autoradiographic study of the fate of diazepam-C14 in the monkey brain. Arch. int. Pharmacodyn. 194, 68–77 (1971)
Marcucci, F., Fanelli, R., Mussini, E.: A method for gas chromatographic determination of benzodiazepines. J. Chromatogr. 37, 318–320 (1968)
Van der Kleijn, E.: Pharmacokinetics of distribution and metabolism of ataractic drugs and an evaluation of the site of antianxiety activity. Ann. N. Y. Acad. Sci. 179, 115–125 (1971)
Van der Kleijn, E., van Rossum, J. M., Muskens, E. T., Rijntjes, N. V.: Pharmacokinetics of diazepam in dogs, mice and humans. Acta pharmacol. (Kbh.) 29, 109–127 (1971)
Wahler, H. J.: The physical symptoms inventory: Measuring levels of somatic complaining behavior. J. clin. Psychol. 24, 207–211 (1968)
Zung, W. W. K.: A self-rating depression scale. Arch. gen. Psychiat. 12, 63–70 (1965)
Author information
Authors and Affiliations
Additional information
This study was carried out at Prince Henry Hospital, Sydney. The principal author was then a research fellow of the School of Psychiatry, University of New South Wales with a grant from Pfizer, Australia Ltd. The chromatography was performed in the Department of Pharmacology, University of Melbourne, Parkville, Victoria.
Rights and permissions
About this article
Cite this article
Bianchi, G.N., Fennessy, M.R., Phillips, J. et al. Plasma level of diazepam as a therapeutic predictor in anxiety states. Psychopharmacologia 35, 113–122 (1974). https://doi.org/10.1007/BF00429578
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00429578